Former Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals · Bausch & Lomb Corp (BLCO)

Christina Ackermann

A named executive officer of Bausch & Lomb in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$6,091,013

Salary $246,635Stock awards $1,791,652Bonus $250,000

FY2022: $4,735,526

3rd of 8 named executive officers at Bausch & Lomb by FY2023 total.

8 named officers on file for Bausch & Lomb, FY2023

Christina Ackermann’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • BLCO’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bausch & Lomb’s whole pay program stands against its peers

  • Bausch & Lomb’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BLCO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Christina Ackermann’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Christina Ackermann compensation by year

Bausch & Lomb Summary Compensation Table · all 4 fiscal years held
In US dollars, as Bausch & Lomb reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$743,654$750,000$750,000$246,635
Bonus$0$0$0$250,000
Stock awards$1,692,387$2,348,225$2,063,144$1,791,652
Option awards$540,362$600,033$1,499,999$499,999
Non-equity incentive$540,000$862,000$402,000$205,766
Pension and deferred compensation$0$0$0$0
All other$24,625$14,330$20,383$3,096,961
Total$3,541,028$4,574,588$4,735,526$6,091,013

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bausch & Lomb Corp DEF 14A filed April 29, 2024, accession 0001308179-24-000628, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bausch & Lomb Corp filed document, accession 0001308179-24-000628. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$3.5M
$4.6M
$4.7M
$6.1M
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option130,845—$18.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Bausch & Lomb Corp's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Bausch & Lomb’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Brenton SaundersChairman of the Board and Chief Executive Officer$45,309,051
Joseph PapaFormer Chief Executive Officer$9,528,086
Christina Ackermann · this pageFormer Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals$6,091,013
Joseph GordonFormer President, Global Consumer, Surgical and Vision Care$5,260,130
A. Robert BaileyExecutive Vice President & Chief Legal Officer$5,214,599
Sam EldessoukyExecutive Vice President and Chief Financial Officer$4,757,166
Yehia HashadExecutive Vice President of Research & Development and Chief Medical Officer$2,657,494
Andrew StewartPresident, Global Pharmaceuticals and International Consumer$1,933,266

The full Bausch & Lomb compensation record

free company brief

This page is one person within Bausch & Lomb's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Bausch & Lomb proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bausch & Lomb's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Christina Ackermann's compensation dossier · One-time report. No refunds.